ArticleJournal of medicinal chemistry2020

Synthetic Lethality in Pancreatic Cancer: Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with Olaparib.

Greta Bagnolini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.